Parasite to Prevention
This international conference brought together leading researchers and industry representatives who will review important recent findings in parasite and vector biology, disease pathophysiology and immunology, disease treatment, prevention and control. Attendees learned about the latest developments in key areas and initiatives that are at the forefront of malaria research.
Why Parasite to prevention?
- Internationally renowned invited speakers and scientific committee
- All participants invited to submit abstracts for oral and poster presentations. A significant number of talks will be selected from conference registrants
- Highly topical scientific program: from parasite cell biology to immunology, vaccination and control
- This event is a must-attend for all: postdoctoral research fellows; graduate students; principal investigators in academia and industry; clinical researchers working in malariology.
- Parasite and vector cell biology
- Disease pathogenesis
- Drug discovery
- Immunology and vaccine development
- Disease control
Malaria remains one of the most serious health problems worldwide and is responsible for between one and three million deaths annually. Even if the current trend towards a reduction of malaria incidence as a result of better anti-malarial drugs and intensified use of effective control measures continues, the situation is fragile due to the spread of drug-resistant parasites and insecticide-resistant vectors.
This meeting will explore important recent findings in parasite and vector biology, disease pathophysiology and immunology, as well as disease treatment, prevention and control. In this fast-moving discipline, there is a need for the scientific community to take the opportunity to meet and review significant progress.
Session 1:Advances in understanding parasite biology and host-parasite interactions that are relevant to disease and treatment
Session 2:Assimilating genome-wide analyses of parasites to provides new tools for vaccines and drug discovery projects, as well as understanding the mechanisms of resistance
Session 3: Vector biology: New approaches to vector control of plasmodium parasites
Session 4: Emerging parasites: recently discovered knowlesi in humans that is providing new insights into pathophysiology of malarial infections
Session 5: Revisiting the sequestration and cytokine/mediator models for pathogenesis
Session 6: Drug discovery – renewed vision and role in malaria control and elimination
Session 7: Immunology and vaccine development
Session 8: Disease Control: Vector control options are constantly evolving, whether by pesticide, sterile insect technique or biological control. What else is on the horizon?
Researchers, clinicians, graduate students, post doctoral fellows, health organizations and all who are interested in malaria and public health.
Cutting edge presentations will be delivered by internationally renowned researchers. Short oral platform presentations and posters will be selected from registrants submitted abstracts.
Marcel Hommel, University of Liverpool, Editor-in-Chief Malaria Journal, UK
Sanjeev Krishna, St George’s University of London, UK
Stephen Lindsay, London School of Hygiene & Tropical Medicine, UK
David Sullivan, Johns Hopkins University, USA
Henri Vial, CNRS, University Montpellier, France
Kiaran Kirk, The Australian National University, Australia
Stephen Ward, Liverpool School of Tropical Medicine, UK
BioMed Central is an STM (Science, Technology and Medicine) publisher that has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.